Novocure (NVCR) Tops Q2 EPS by 9c

Novocure (NASDAQ: NVCR) reported Q2 EPS of ($0.31), $0.09 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $150.4 million versus the consensus estimate of $135.83 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• Citigroup (C) Tops Q2 EPS by 42c
• Shake Shack (SHAK) PT Lowered to $66 at Piper Sandler
• Goldman Sachs on JPMorgan (JPM): 'We believe the results were modestly positive'